---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-000930"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T04:22:36.750235+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Windtree appoints Leanne Kelly to board; launches strategy to acquire small biotechs with equity

## Summary
- Leanne Kelly appointed as independent director and Audit Committee chair effective Jan 8, 2025.
- CEO states new corporate strategy: use equity to acquire small biotechs with FDA-approved products to become revenue-generating.
- Company received Nasdaq deficiency notice Dec 4, 2024 for independent director/audit committee; expects Kelly's appointment to resolve.
- Kelly is currently CFO of GRI Bio, with over 20 years of public company experience in life sciences and accounting.

## SEC filing metadata
- accession: 0001437749-25-000930
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774925000930/0001437749-25-000930-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774925000930/wint20250112_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-000930
- JSON: https://secwatch.observer/filing/0001437749-25-000930.json
- Plain text: https://secwatch.observer/filing/0001437749-25-000930.txt

## Key facts
- Executive change
  Leanne Kelly was appointed as director and chair of the Audit Committee at WINDTREE THERAPEUTICS INC /DE/.
  - Action: appointed
  - Role: director and chair of the Audit Committee
  source text: On January 8, 2025, the Board of Directors (the "Board") of Windtree Therapeutics, Inc. (the "Company") approved an increase in the number of directors on the Board to five and appointed Leanne Kelly as a director and member and chair of the Audit Committee, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774925000930/0001437749-25-000930-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.